Loading
Latest filing published 09 Mar 2026 for Cannara Biotech Inc..
No signal scores available.
Brian Sherman is a declared insider of Cannara Biotech Inc., with filings sourced from SEDI. In total, 6 filings cover trades dated from 4 October 2021 to 28 February 2025.
The open-market record is one-sided, with 4 purchases worth €4,054 and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2026 to date brings 1 purchase and no sales.
A typical purchase (the median) is worth €1,080.
The newest entry dates from 9 March 2026: a transaction, in Cannara Biotech Inc. The clock since the last published purchase (9 March 2026) now reads 232 days. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations